The Pharma Data

AUGUST 18, 2020

CARE will focus on three strategic pillars to achieve therapeutic breakthroughs against SARS-CoV-2 (the virus that causes COVID-19 disease) and other coronavirus threats: Drug repositioning and repurposing. The current pandemic demonstrates just how serious certain coronaviruses have become as a public health concern.

Development 52

Development Research Containment Production 52

Crucial Data Soutions

APRIL 27, 2020

The COVID-19 pandemic that struck the globe this year has drastically disrupted the state of affairs in the life sciences industry. Or, they’ve found themselves needing to think differently about the design of their upcoming studies, eating up valuable time and resources.

Clinical Trials 85

Clinical Trials Clinical Trials Trials Life Science 85

The Pharma Data

APRIL 15, 2022

The findings were published yesterday (April 12) in the journal Science Translational Medicine. To begin, the team first used supercomputers to design proteins that could stick to vulnerable sites on the surface of the novel coronavirus, targeting the spike protein. This work was originally reported in 2020 in the journal Science.

Antibody 52

Antibody Protein Engineer Manufacturing 52

The Pharma Data

JULY 18, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for use in individuals 12 years of age and older.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

pharmaphorum

OCTOBER 8, 2020

He highlights GSK’s “unprecedented” partnership with Sanofi, where the two companies are combining their science and technologies to develop an adjuvanted COVID-19 vaccine, which entered clinical trials in September 2020. With COVID, even the approach to vaccine discovery is transforming”.

Vaccination 111

Vaccination Vaccine Clinical Trials Clinical Trials 111

pharmaphorum

MAY 18, 2022

The value of external science and strategic collaboration. To stem these demands, complement internal pipelines with promising external science and create differentiated value for patients, a lot of pharmaceutical companies are currently looking for strategic collaborations and acquisitions.

Gene Therapy 92

Gene Therapy Gene Genetics Development 92

pharmaphorum

OCTOBER 2, 2020

There’s massive pressure on limited resources in healthcare, while systems like the NHS are still mostly only able to focus on curing diseases and not preventing them,” says Ed Hudson, managing director of Create Health. Self-care will even up resources and give a better shape to our healthcare system.”.

Regulation 111

Regulation Doctors Doctor Production 111

The Pharma Data

JANUARY 25, 2021

With a mandate to serve patients and an emphasis on public health, CSL Behring is a co-founder of the CoVIg-19 Plasma Alliance , which aims to develop an anti-coronavirus hyperimmune globulin (H-Ig) made from a convalescent plasma for the treatment of hospitalized adults at risk for serious complications of COVID-19. “It

Antibody 52

Antibody Trials Vaccination Vaccine 52

The Pharma Data

DECEMBER 12, 2020

Food and Drug Administration approved Pfizer’s coronavirus vaccine for emergency use on Friday, clearing the way for the launch of a national campaign to inoculate enough Americans to stem the spread of COVID-19. SATURDAY, Dec. 12, 2020 – The U.S. The emergency approval comes not a moment too soon. The companies have negotiated a $2.1

FDA Approval 52

FDA Approval Vaccination Vaccine Nurses 52

The Pharma Data

NOVEMBER 12, 2020

While the CALAVI results are disappointing, we remain committed to advancing science that helps patients during this unprecedented global pandemic, including clinical trials for the AstraZeneca Oxford coronavirus vaccine and our long-acting antibody combination.”. More News Resources. AstraZeneca. J Hematol Oncol. 2016;9(21).

Trials 52

Trials Clinical Trials Clinical Trials Immune Response 52

The Pharma Data

OCTOBER 27, 2020

The National Academies of Sciences, Engineering, and Medicine (NASEM) recently launched a set of vaccine allocation guidelines for the United States, identifying 13 high-priority populations to be vaccinated in phases: Phase 1A includes high-risk workers in health facilities and first responders. Chan School of Public Health.

Vaccination 52

Vaccination Vaccine Engineer Development 52

The Pharma Data

JUNE 24, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for use in individuals 12 years of age and older. IMPORTANT SAFETY INFORMATION FROM U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

MAY 4, 2021

“ Lilly ‘s action provides both important new options and potential resources for countries’ health and regulatory leaders to consider for the care of COVID-19 patients, and Direct Relief will of course move with urgency upon receiving any such requests.” BC HCP EUA ISI 19NOV2020.

Antibody 52

Antibody Medicine FDA Approval Licensing 52

The Pharma Data

JANUARY 11, 2021

“Having appropriate resources in place is essential for aiding recovery in the painful and long months after acute infection.” It found that levels of neutralizing antibodies against the new coronavirus fell by more than half (52.5%) after six months in 94 patients whose immune response was tested at the peak of the infection. .

Immune Response 52

Immune Response Vaccination Vaccine Antibody 52

The Pharma Data

MARCH 22, 2022

Nirmatrelvir [PF-07321332], which originated in Pfizer laboratories, is designed to block the activity of the Mpro, an enzyme that the coronavirus needs to replicate. 360bbb-3(b)(1), unless the declaration is terminated or authorization revoked sooner.

In-Vitro 52

In-Vitro Contract Manufacturing Manufacturing Production 52

Pfizer

OCTOBER 31, 2022

This has been driven by a range of factors including already under-resourced health systems now overburdened by the direct impacts of COVID-19; increased fear and concern of the virus hindering health seeking behaviors; and the secondary impacts of the pandemic on peoples’ livelihoods and food security, among many others. 10.28.2022.

Vaccination 40

Vaccination Vaccine Medicine Clinical Trials 40

The Pharma Data

DECEMBER 3, 2020

Richard Hatchett, Chief Executive Officer of CEPI commented, “This vaccine candidate has the potential to be manufactured at scale and stored in a regular refrigerator which makes it suitable for use around the globe, including in low-resource settings. CEPI has initiated nine partnerships to develop vaccines against the novel coronavirus.

Vaccination 52

Vaccination Vaccine Immune Response Protein 52

The Pharma Data

DECEMBER 23, 2020

. INO-4800 is INOVIO’s DNA vaccine candidate against SARS-CoV-2, the novel coronavirus that causes COVID-19. Composed of an optimized DNA plasmid, INO-4800 is delivered directly into cells in the body via a proprietary smart device to produce a robust, safe and tolerable immune response. .

DNA 40

DNA Vaccination Vaccine Immune Response 40

Pfizer

JANUARY 27, 2023

Nirmatrelvir, which originated in Pfizer laboratories, is designed to block the activity of the M pro , an enzyme that the coronavirus needs to replicate. About Pfizer: Breakthroughs That Change Patients’ Lives At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Marketing 75

Marketing Production Drugs Licensing 75

The Pharma Data

FEBRUARY 25, 2021

It invests extensively in dynamic and comprehensive R&D resources and a modern, global supply chain. For 130 years, Merck, a leading global biopharmaceutical company, has been inventing for life, bringing forward medicines and vaccines for many of the world’s most challenging diseases. Merck Animal Health, a division of Merck & Co.,

Production 52

Production Vaccination Vaccine Marketing 52

The Pharma Data

OCTOBER 22, 2020

22, 2020– Gilead Sciences, Inc. that is available for all appropriate patients in need,” said Daniel O’Day, Chairman and Chief Executive Officer, Gilead Sciences. About Gilead Sciences. Gilead Sciences, Inc. Gilead, the Gilead logo and Veklury are trademarks of Gilead Sciences, Inc. FOSTER CITY, Calif.–(BUSINESS

FDA Approval 52

FDA Approval Trials Clinical Trials Clinical Trials 52

pharmaphorum

JULY 1, 2021

Only a year after the emergence of COVID-19, a handful of life science companies started publishing data on the encouragingly high efficacy of their vaccine candidates. It’s a miracle of modern science, but it didn’t happen in a single flash of brilliance out of the blue.

Vaccination 103

Vaccination Vaccine Development Life Science 103

The Pharma Data

JULY 21, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) for use in individuals 12 years of age and older. IMPORTANT SAFETY INFORMATION FROM U.S.

Manufacturing 52

Manufacturing Vaccination Vaccine Clinical Trials 52

The Pharma Data

APRIL 16, 2021

For media resources, including product images and fact sheets, please click here. Lilly licensed etesevimab from Junshi Biosciences after it was jointly developed by Junshi Biosciences and the Institute of Microbiology, Chinese Academy of Science (IMCAS). Click here for resources related to Lilly’s COVID-19 efforts.

Antibody 52

Antibody Development Medicine Protein 52

The Pharma Data

MAY 7, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S.

Licensing 52

Licensing Licensing Vaccination Vaccine 52

The Pharma Data

OCTOBER 30, 2020

The fifth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus disease (COVID-19) took place on Thursday, 29 October 2020 from 12:30 to 16:05 Geneva time (CEST). Proceedings of the meeting. Essential Health Services 12. Source link.

Regulation 52

Regulation Vaccination Vaccine Compliance 52

The Pharma Data

MAY 6, 2021

Food and Drug Administration (FDA), but has been authorized for emergency use by FDA under an Emergency Use Authorization (EUA) to prevent Coronavirus Disease 2019 (COVID-19) for use in individuals 16 years of age and older. The Pfizer-BioNTech COVID-19 Vaccine has not been approved or licensed by the U.S.

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

About AstraZeneca AstraZeneca (LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

SEPTEMBER 8, 2020

LSE/STO/NYSE: AZN) is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three therapy areas – Oncology, Cardiovascular, Renal & Metabolism, and Respiratory & Immunology. About AstraZeneca.

Vaccination 52

Vaccination Vaccine Containment Clinical Trials 52

The Pharma Data

DECEMBER 11, 2020

Historic science-driven efforts will seek to help bring an end to the most devastating pandemic in a century. We have worked tirelessly to make the impossible possible, steadfast in our belief that science will win.”. “We NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. “As

Vaccination 52

Vaccination Vaccine Clinical Trials Clinical Trials 52

The Pharma Data

APRIL 27, 2021

the Pfizer-BioNTech COVID-19 vaccine) has been granted conditional marketing authorisation by the European Medicines Agency to prevent coronavirus disease 2019 (COVID-19) in people from 16 years of age. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Vaccination 52

Vaccination Vaccine Manufacturing Clinical Trials 52

Pfizer

JANUARY 27, 2023

Fact-based information rooted in sound science is vitally important to overcoming the COVID-19 pandemic and Pfizer remains committed to transparency and helping alleviate the devastating burden of this disease. It is important to note that these studies are required by U.S. and around the world.

Research 112

Research Vaccination Vaccine Drugs 112

Delveinsight

AUGUST 13, 2021

With the unprecedented twist in the routine lives due to the ongoing Coronavirus pandemic, the approach to conduct and hold clinical trials seems to be readjusting. The conduct of trials was not possible due to the risk of catching coronavirus. The availability of collective databases in a single place is of major concern.

Clinical Trials 98

Clinical Trials Clinical Trials Trials Drugs 98

Pfizer

DECEMBER 13, 2022

Nirmatrelvir [PF-07321332], which originated in Pfizer laboratories, is designed to block the activity of the Mpro, an enzyme that the coronavirus needs to replicate. At Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives.

Drugs 110

Drugs Licensing Licensing Production 110

Pfizer

JULY 26, 2022

Pfizer-BioNTech COVID-19 Vaccine is FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. . Indication & Authorized Use. COMIRNATY® INDICATION.

Vaccination 111

Vaccination Vaccine Protein Immune Response 111

pharmaphorum

NOVEMBER 19, 2021

The mRNA jab, developed by Pfizer and BioNTech, launched to huge fanfare in December 2020 and promised the start of the end of the coronavirus pandemic. The covid vaccine roll out is arguably the best example of why communications, and specifically behavioural science as part of that, plays such a pivotal role in healthcare.”.

Sales 137

Sales Vaccination Vaccine Marketing 137

Pfizer

JULY 8, 2022

Pfizer-BioNTech COVID-19 Vaccine is FDA authorized under Emergency Use Authorization (EUA) for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 6 months of age and older. . Indication & Authorized Use . COMIRNATY® INDICATION.

FDA Approval 102

FDA Approval Vaccination Vaccine Clinical Trials 102